Photo: <a href="https://depositphotos.com" target="_blank">Depositphotos</a>
Sep 22, 2025, 13:37
Pregnancy in Sickle Cell Disease: Addressing the Underrecognized Risk of Venous Thromboembolism
American Society of Hematology shared a post on LinkedIn:
“Pregnancy in sickle cell disease carries a high risk of thrombotic complications, yet guidance on anticoagulation remains inconsistent.
Chronic hypercoagulability and prior thrombotic events heighten these risks, making early recognition, individualized care, and preventive strategies essential.
Collaborative, multidisciplinary approaches and evidence-based anticoagulation protocols can help improve outcomes for this vulnerable population.”
Title: Venous Thromboembolism in Sickle Cell Disease: A Critical and Underrecognized Maternal Health Risk
Authors: Sacha Choupa
Read the full article here.
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch
-
Feb 23, 2026, 16:36Stéphanie Roullet։ New Method to Explore Primary Haemostasis in Cirrhotic Patients
-
Feb 23, 2026, 16:33Salvatore Massimo Petrina: Top 5 Game-Changers in the AHA and ACC PE Guidelines
-
Feb 23, 2026, 16:21Azin Alizadehasl: Introducing the Second Edition of a New Book on Echocardiography and Cardiac MRI
-
Feb 23, 2026, 16:16Kalyan Roy: When and Why Blood Irradiation Matters in Transfusion Medicine
-
Feb 23, 2026, 15:59Ney Carter Borges: Antithrombotic Therapy in 2025 – A Precision-Based Pharmacologic Update
-
Feb 23, 2026, 15:54Alan Nurden: From Early Discoveries to New Therapeutic Advances in von Willebrand Disease
-
Feb 23, 2026, 15:52Gevorg Tamamyan: Albania’s Vision for the Future of Pediatric Oncology
-
Feb 23, 2026, 15:36Simon Senanu: The Peripheral Blood Smear as an Essential Diagnostic Tool in Modern Medicine